近期药物发现领域的进展,用于三阴性乳腺癌治疗
Domiziana Masci1, Chiara Naro2,3, Michela Puxeddu4
1Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.
Molecules (Basel, Switzerland)
|November 25, 2023
概括
三阴性乳腺癌 (TNBC) 是具有攻击性和难以治疗的. 新兴疗法,包括新的药物和组合,有望改善这种具有挑战性的癌症患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 三阴性乳腺癌 (TNBC) 是乳腺癌的一种高度侵袭性和异质的亚型.
- 由于缺乏向治疗选择,TNBC存在重大治疗挑战.
- 甲状腺癌的复发与高死亡率有关.
研究的目的:
- 审查TNBC目前的标准疗法.
- 探索新兴的治疗策略和TNBC的新药开发.
- 突出小分子,重新定位药物和组合疗法的潜力,以提高TNBC治疗疗效.
主要方法:
- 对当前和新兴TNBC治疗方法的文献综述.
- 对TNBC分子特征的近期进展进行分析.
- 综合有关新型小分子,重新定位药物和组合疗法的数据.
主要成果:
- 目前的TNBC治疗方法有限,需要新的方法.
- 分子理解的进步正在推动新的治疗策略的开发.
- 早期证据表明,小分子,药物重新定位和组合疗法具有前景.
结论:
- 新的治疗策略对于改善TNBC治疗结果至关重要.
- 针对性疗法和组合方法对管理TNBC具有显著的前景.
- 对分子驱动因素和药物开发的持续研究对于推进TNBC护理至关重要.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


